Peters, K. B., Kirkpatrick, J. P., Batinic-Haberle, I., Affronti, M. L., Woodring, S., Iden, D., … Crapo, J. (2019). First in Human Clinical Trial of a Metalloporphyrin Dual Radioprotectant and Radiosensitizer, BMX-001, in Newly Diagnosed High-Grade Glioma Undergoing Concurrent Chemoradiation. In International Journal of Radiation Oncology*Biology*Physics (Vol. 105, pp. E106–E106). Chicago, IL: Elsevier BV. https://doi.org/10.1016/j.ijrobp.2019.06.2305

Peters, K. B., J. P. Kirkpatrick, I. Batinic-Haberle, M. L. Affronti, S. Woodring, D. Iden, E. S. Lipp, et al. “First in Human Clinical Trial of a Metalloporphyrin Dual Radioprotectant and Radiosensitizer, BMX-001, in Newly Diagnosed High-Grade Glioma Undergoing Concurrent Chemoradiation.” In International Journal of Radiation Oncology*Biology*Physics, 105:E106–E106. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.2305.

Peters KB, Kirkpatrick JP, Batinic-Haberle I, Affronti ML, Woodring S, Iden D, et al. First in Human Clinical Trial of a Metalloporphyrin Dual Radioprotectant and Radiosensitizer, BMX-001, in Newly Diagnosed High-Grade Glioma Undergoing Concurrent Chemoradiation. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2019. p. E106–E106.

Peters, K. B., et al. “First in Human Clinical Trial of a Metalloporphyrin Dual Radioprotectant and Radiosensitizer, BMX-001, in Newly Diagnosed High-Grade Glioma Undergoing Concurrent Chemoradiation.” International Journal of Radiation Oncology*Biology*Physics, vol. 105, no. 1, Elsevier BV, 2019, pp. E106–E106. Manual, doi:10.1016/j.ijrobp.2019.06.2305.

Peters KB, Kirkpatrick JP, Batinic-Haberle I, Affronti ML, Woodring S, Iden D, Lipp ES, Boyd K, Healy P, Herndon J, Spasojevic I, Penchev S, Gad S, Silberstein D, Johnson MO, Randazzo D, Desjardins A, Friedman HS, Ashley DM, Crapo J. First in Human Clinical Trial of a Metalloporphyrin Dual Radioprotectant and Radiosensitizer, BMX-001, in Newly Diagnosed High-Grade Glioma Undergoing Concurrent Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2019. p. E106–E106.